Home >
News >
EXTENDED DEADLINE FOR ABSTRACTS: MAY 17, 2020 - JOHN GOLDMAN CONFERENCE
EXTENDED DEADLINE FOR ABSTRACTS: MAY 17, 2020 - JOHN GOLDMAN CONFERENCE
May 05, 2020
22nd ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY
October 2-4, 2020
Mandelieu-La Napoule, France
Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger,
Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa
Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent,
Rick Van Etten
EXTENDED DEADLINE FOR ABSTRACTS
FOR ORAL AND POSTER PRESENTATIONS:
May 17, 2020
ABOUT THE PROGRAMME:
Speakers at this meeting will present the newest and often unpublished data relating to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.
The programme will include:
- John Goldman Prize lecture
- Janet Rowley Prize lecture
- iCMLf Prize lecture
- Keynote lectures
- Special lectures
- Workshops for non-clinical scientists
- Oral communications selected from submitted abstracts
- Brief oral communications selected from submitted abstracts
- Meet-the-Expert Sessions
- Clinical and biology Manned Poster Walks
- Special Saturday symposium 2020
- The ESH International John Goldman Research Award presentation 2020
Main Topics:
- Stem Cells and the microenvironment
- Molecular biology and new targets
- Proteomics and Secretomics
- Artificial Intelligence and Machine Learning
- Mechanisms of resistance and disease progression
- Biomarkers
- Immunology and Inflammation
- Therapeutic interventions
- Immunotherapy
- Treatment free remission
- Safety and patient reported outcomes
- Clinical trial design
- The new ELN recommendations
- New drugs in development
LEUKAEMIA UK INTERNATIONAL SCHOLARSHIPS
This Call for Applications is made thanks to a funding support from:
The present Call for Applications may be of interest to you if you are:
- Fully trained, with a maximum of 4 years experience since your first junior faculty appointment
- A senior clinical resident or a PhD candidate
Extended deadline for applications:
May 17, 2020
Stay tuned for announcements regarding other ESH Scholarship Fund scholarships.
With the support of*:
Emerald Conference Partners
********
Ruby Conference Partner
********
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.